| Patents for C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups (15,621) |
|---|
| 02/24/2004 | US6696435 For treating atherosclerosis, other coronary artery diseases; 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for example |
| 02/24/2004 | CA2217880C Synthesis of optically active aminoindanol |
| 02/19/2004 | WO2004014844A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 02/19/2004 | WO2004014424A1 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 02/19/2004 | WO2003082190A3 Spirocyclic amides as cannabinoid receptor modulators |
| 02/19/2004 | WO2003065989A3 (oxime)carbamoyl fatty acid amide hydrolase inhibitors |
| 02/19/2004 | WO2003024402A3 Lpa receptor agonists and antagonists and methods of use |
| 02/19/2004 | US20040034246 Radiofluorinated imaging agents which are utilzed in Positron Emission Tomography for diagonsis of Parkinson's disease |
| 02/19/2004 | US20040034070 Propanolaminotetralines, preparation thereof and compositions containing same |
| 02/19/2004 | US20040034048 Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same |
| 02/19/2004 | US20040033995 Nitrogen compounds, stereoisomers and/or racemic mixtures used as enzyme inhibitors for prophylaxis of inflammatory diseases |
| 02/19/2004 | CA2493008A1 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 02/18/2004 | EP1389182A1 Complexes for transferring substances of interest into a cell |
| 02/18/2004 | EP1389181A2 Antioxidant nitroxides and nitrones as therapeutic agents |
| 02/18/2004 | EP1292572B1 Propanolaminotetralines, preparation thereof and compositions containing same |
| 02/18/2004 | EP1178958B1 N-cyanomethyl amides as protease inhibitors |
| 02/18/2004 | EP0980351B1 Benzylamine and phenylethylamine derivatives, processes for preparing the same and their use as medicaments |
| 02/18/2004 | CN1475481A Method of synthesizing methyl carbamate |
| 02/18/2004 | CN1138472C Dipeptide apoptosis inhibitors and use thereof |
| 02/17/2004 | US6693205 Process for preparing optically active epoxides |
| 02/17/2004 | US6693123 (4-(3-pyridylaminomethylene)-2-phenylbenzoyl)-n -methylmethionine, methyl ester for example; restenosis, hyperplasia |
| 02/17/2004 | US6693099 Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance |
| 02/17/2004 | US6693098 Carboxylic acid or tetrazole derivatives containing carbamate groups are useful for treating the conditions associated with the urinary tract, pain, inflammation, respiratory states, edema formation of hypotensive vascular diseases |
| 02/12/2004 | WO2004013077A2 Cyclopentanone and cyclopentanone derivatives as potent activators of hsf-1 |
| 02/12/2004 | US20040030176 Gamma hydroxy carbamate compounds and method of making and using the same |
| 02/12/2004 | US20040030144 Reacting an amino acid with organometallic compound; cyclization |
| 02/12/2004 | US20040030132 Anticancer agents; arterosclerosis; bone disorders; antiarthritic agents; vision defects |
| 02/12/2004 | US20040029967 Phenylethylamine derivatives and their use in the treatment of melanoma |
| 02/12/2004 | US20040029929 Aminoadamantane derivatives as therapeutic agents |
| 02/12/2004 | US20040029814 Cathepins inhibitor; antiinflammatory agents; antiarthritic agents |
| 02/12/2004 | US20040029735 Substituted herbicidal phenyluracils |
| 02/12/2004 | CA2495030A1 Cyclopentanone and cyclopentanone derivatives as potent activators of hsf-1 |
| 02/11/2004 | EP1387831A1 Substituted arylketones |
| 02/11/2004 | EP1212332B1 Fungicides |
| 02/11/2004 | CN1474805A 2-amino-2-alkyl-5-heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/11/2004 | CN1474804A 2-amino-2-alkyl-4-hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/10/2004 | US6689897 Intermediates of CETP inhibitors |
| 02/05/2004 | WO2004011523A2 Novel phase change solvents |
| 02/05/2004 | US20040024229 Production method for biarylalanine |
| 02/05/2004 | US20040024220 Lipids |
| 02/05/2004 | US20040024136 Degradable carbamate-containing bis(acryloyl) crosslinkers, and degradable crosslinked hydrogels comprising them |
| 02/05/2004 | US20040024059 Novel pleuromutilin derivatives |
| 02/05/2004 | US20040024057 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use related applications |
| 02/05/2004 | US20040023986 Treating epilepsy, neuropathic pain, and tissue damage form ischemic events; antihypoxic agents |
| 02/05/2004 | US20040023806 Agrochemicals in agriculture for controlling acarids and insects and for preventing the infestation of crop plants by phytopathogenic fungi. |
| 02/05/2004 | US20040023290 Novel therapeutic agents that modulate enzymatic processes |
| 02/05/2004 | US20040022856 Carriers for drug delivery |
| 02/05/2004 | US20040021130 Novel phase change solvents |
| 02/04/2004 | CN1473145A Method of resolving optical isomers of amino acid derivative |
| 02/03/2004 | US6686477 Multistep chemical synthesis, including asymmetric hydrogenation of a lactam-enamide to produce an intermediate that can be used to make unspecified pharmaceuticals |
| 02/03/2004 | US6686470 Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof |
| 02/03/2004 | US6686395 2′-substituted 1,1′-biphenyl-2-carboxamides, process for their preparation, their use as medicaments, and pharmaceutical preparations comprising them |
| 02/03/2004 | US6686335 Hydroxamate-containing cysteine and serine protease inhibitors |
| 01/29/2004 | WO2003059864A3 Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity |
| 01/29/2004 | US20040019216 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 01/29/2004 | US20040019017 Caspase inhibitor prodrugs |
| 01/29/2004 | US20040018598 Chemical intermediate for discodermolide, epothilone |
| 01/28/2004 | EP1383799A1 Probes, systems and methods for drug discovery |
| 01/28/2004 | EP1383760A1 Biarylcarboxamide compounds as apolipoprotein b inhibitors |
| 01/28/2004 | EP1383739A1 New compounds |
| 01/28/2004 | EP1383738A2 Alkyl and/or alkenyl glycerol carbamates |
| 01/28/2004 | EP1383737A1 Process for the preparation of alkyl-n-(3-dimethylamino)alkylcarbamates |
| 01/28/2004 | EP1383734A2 Compounds useful as intermediates for 4-aminoquinoline derivatives |
| 01/28/2004 | EP1383731A1 Biaryl compounds as serine protease inhibitors |
| 01/28/2004 | CN1471509A 9-substituted minocycline compounds |
| 01/28/2004 | CN1136451C Use of certain amides |
| 01/28/2004 | CN1136189C Substituted heterocyclic compounds, preparing method thereof and pharmaceutical composition containig them |
| 01/27/2004 | US6683214 Reacting a n-protected aminoacid ester with halomethyllithium compound; then acid |
| 01/27/2004 | US6683201 Analine derivatives as OSC inhibitors |
| 01/27/2004 | US6683099 Substituted N,N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/22/2004 | WO2004007427A1 N-methyl amino acids |
| 01/22/2004 | US20040014940 Methods for synthesis of acyloxyalkyl derivatives of GABA analogs |
| 01/21/2004 | EP1382591A1 Novel atisane compound and use thereof |
| 01/21/2004 | EP1382333A2 Use of beta 3 adrenergic receptor agonists in the treatment of dysuria |
| 01/21/2004 | EP1381597A2 Processes and intermediates for preparing benzyl substituted epoxides |
| 01/21/2004 | EP1381591A2 Certain salts of discodermolide acid, pharmaceutical compositions containing them and their use in treating tumors |
| 01/21/2004 | EP1282601B1 Process and intermediates for the preparation of 1-(9h-carbazol-4-yloxy)-3-[2-(2-methoxy-phenoxy)-ethylamino]-propan-2-ol, carvedilol or acid addition salt thereof |
| 01/21/2004 | CN1469888A Use as catalyst for forming urethanes, of fluorinated and trivalent metal acid salts, composition containing same and methods using same |
| 01/21/2004 | CN1469777A Use of tin derivatives as catalysts for transforming carbamates, carbamate compositions comprising said catalyst and method for transforming carbamates |
| 01/20/2004 | US6679663 Locking nut, bolt and clip systems and assemblies |
| 01/15/2004 | WO2004005229A1 Modulators of the glucocorticoid receptor |
| 01/15/2004 | WO2004004648A2 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 01/15/2004 | US20040010038 Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitors |
| 01/15/2004 | US20040009982 Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof |
| 01/15/2004 | US20040009923 Alpha-substituted methyl ketones derived from aspartic acid and the closed hemi-ketal forms thereof |
| 01/15/2004 | CA2491994A1 Modulators of the glucocorticoid receptor |
| 01/15/2004 | CA2491127A1 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 01/14/2004 | EP1380568A2 Perfluoroalkylaniline derivatives |
| 01/14/2004 | EP1380562A1 Carboxylic acid derivative and salt thereof |
| 01/14/2004 | EP1379521A1 Delta1-pyrrolines |
| 01/14/2004 | EP1379516A1 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as ip antagonists |
| 01/14/2004 | EP1379495A2 Ligands of the alpha-v-beta 6 integrin |
| 01/14/2004 | EP1379493A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses |
| 01/14/2004 | CN1468226A Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 01/14/2004 | CN1468214A Novel derivatives of aminocyclohexane |
| 01/14/2004 | CN1468211A Nitroso diphenylamine derivatives |
| 01/14/2004 | CN1134411C Bicyclic amino derivatives and PGD2 antagonist containing same |
| 01/13/2004 | US6677487 Combining a tertiary amide with a pentavalent phosphorous halide in a solvent to form an alpha - haloiminium salt and converting the alpha -haloiminium salt to the alpha -haloenamine with a base |
| 01/13/2004 | US6677431 Design, preparation, and properties of antibacterial β-peptides |
| 01/13/2004 | US6677382 Halogenated oxyamines, used as enzyme inhibitors for prophylaxis of atherosclerosis and cardiovascular disorders, and as antilipemic agents |